These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 10719024

  • 1. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [Abstract] [Full Text] [Related]

  • 2. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A, Bishop GA, Bowen DG, Gleeson MM, Guney S, Painter DM, McCaughan GW.
    Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
    Schirren CA, Jung MC, Worzfeld T, Mamin M, Baretton G, Gerlach JT, Gruener NH, Zachoval R, Houghton M, Rau HG, Pape GR.
    J Infect Dis; 2001 Apr 15; 183(8):1187-94. PubMed ID: 11262200
    [Abstract] [Full Text] [Related]

  • 4. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F, Giostra E, Rubbia-Brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A.
    J Med Virol; 1998 Nov 15; 56(3):224-9. PubMed ID: 9783689
    [Abstract] [Full Text] [Related]

  • 5. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, Futagawa S.
    Surg Today; 2003 Nov 15; 33(6):421-5. PubMed ID: 12768367
    [Abstract] [Full Text] [Related]

  • 6. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E.
    Cytokine; 2004 Jul 07; 27(1):7-14. PubMed ID: 15207246
    [Abstract] [Full Text] [Related]

  • 7. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.
    Hepatology; 1999 Jan 07; 29(1):250-6. PubMed ID: 9862874
    [Abstract] [Full Text] [Related]

  • 8. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC, Töx U, Goeser T, Otto G, Müller HM, Hofmann WJ, Stremmel W, Theilmann L.
    Z Gastroenterol; 1997 Apr 07; 35(4):255-61. PubMed ID: 9163889
    [Abstract] [Full Text] [Related]

  • 9. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 07; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 10. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ.
    Liver Transpl; 2009 Nov 07; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.
    Am J Gastroenterol; 1997 Sep 07; 92(9):1458-62. PubMed ID: 9317062
    [Abstract] [Full Text] [Related]

  • 12. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes.
    Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U.
    J Immunol; 1997 Jul 15; 159(2):1012-8. PubMed ID: 9218624
    [Abstract] [Full Text] [Related]

  • 13. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
    Thai NL, Fu F, Qian S, Sun H, Gao L, Wang SC, Demetris AJ, Woo J, Thomson AW, Duquesnoy RJ.
    Transplantation; 1995 Jan 27; 59(2):274-81. PubMed ID: 7530874
    [Abstract] [Full Text] [Related]

  • 14. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines.
    Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW.
    Hepatology; 1996 Oct 27; 24(4):759-65. PubMed ID: 8855173
    [Abstract] [Full Text] [Related]

  • 15. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
    Barnaba V, Franco A, Paroli M, Benvenuto R, De Petrillo G, Burgio VL, Santilio I, Balsano C, Bonavita MS, Cappelli G.
    J Immunol; 1994 Mar 15; 152(6):3074-87. PubMed ID: 7511637
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome of hepatitis C virus infection after liver transplantation.
    Böker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP.
    Hepatology; 1997 Jan 15; 25(1):203-10. PubMed ID: 8985291
    [Abstract] [Full Text] [Related]

  • 17. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
    Kawakami Y, Nabeshima S, Furusyo N, Sawayama Y, Hayashi J, Kashiwagi S.
    Am J Gastroenterol; 2000 Jan 15; 95(1):227-32. PubMed ID: 10638589
    [Abstract] [Full Text] [Related]

  • 18. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E, Raptopoulou-Gigi M, Kalogeridis A, Masiou S, Orphanou E, Vrettou E, Lalla TH, Sinakos E, Tsapas V.
    J Viral Hepat; 2008 Feb 15; 15(2):145-54. PubMed ID: 18184198
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R.
    Acta Med Croatica; 2005 Feb 15; 59(5):443-6. PubMed ID: 16381241
    [Abstract] [Full Text] [Related]

  • 20. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ.
    Hepatology; 2002 Jan 15; 35(1):190-8. PubMed ID: 11786976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.